BioMarin Pharmaceutical Inc. (BMRN) Purchases ZyStor Therapeutics in Deal as Much as $115 Million
8/17/2010 3:09:12 PM
More...
|
ZyStor Therapeutics Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
10/14/2009 11:13:27 AM
More...
|
Crucell N.V. (CRXL) And DSM Biologics Announce PER.C6(R) Licensing Agreement With ZyStor Therapeutics
12/21/2005 4:20:41 PM
More...
|